Formulation and statistical optimization of intravenous temozolomide-loaded PEGylated liposomes to treat glioblastoma multiforme by three-level factorial design

References

• Qu J, Zhang L, Chen Z, et al. Nanostructured lipid carriers, solid lipid nanoparticles, and polymeric nanoparticles: which kind of drug delivery system is better for glioblastoma chemotherapy? Drug Deliv. 2016;23:3408–3416.
   PubMed Web of Science ®Google Scholar
• Laquintana V, Trapani A, Denora N, et al. New strategies to deliver anticancer drugs to brain tumors. Exp Opin Drug Deliv. 2009;6:1017–1032.
   PubMed Web of Science ®Google Scholar
• Wu M, Fan Y, Lv S, et al. Vincristine and temozolomide combined chemotherapy for the treatment of glioma: a comparison of solid lipid nanoparticles and nanostructured lipid carriers for dual drugs delivery. Drug Deliv. 2016;23:2720–2725.
   PubMed Web of Science ®Google Scholar
• Song S, Mao G, Du J, et al. Novel RGD containing, temozolomide-loading nanostructured lipid carriers for glioblastoma multiforme chemotherapy. Drug Deliv. 2016;23:1404–1408.
   PubMed Web of Science ®Google Scholar
• Villano JL, Seery TE, Bressler LR. Temozolomide in malignant gliomas: current use and future targets. Cancer Chemother Pharmacol. 2009;64:647–655.
   PubMed Web of Science ®Google Scholar
• Gao J, Wang Z, Liu H, et al. Liposome encapsulated of temozolomide for the treatment of glioma tumor: preparation, characterization and evaluation. Drug Disc Therapeut. 2015;9:205–212.
   PubMed Web of Science ®Google Scholar
• Lopes IC, de Oliveira SCB, Oliveira-Brett AM. Temozolomide chemical degradation to 5-aminoimidazole-4-carboxamide–electrochemical study. J Electroanal Chem. 2013;704:183–189.
   Web of Science ®Google Scholar
• Diez BD, Statkevich P, Zhu Y, et al. Evaluation of the exposure equivalence of oral versus intravenous temozolomide. Cancer Chemother Pharmacol. 2010;65:727–734.
   PubMed Web of Science ®Google Scholar
• Chang EH, Kim S, Rait A. Targeted liposomes. Google Patents; 2013.
   Google Scholar
• Bae SH, Park M-J, Lee MM, et al. Toxicity profile of temozolomide in the treatment of 300 malignant glioma patients in Korea. J Korean Med Sci. 2014;29:980–984.
   PubMed Web of Science ®Google Scholar
• Debata PR, Curcio GM, Mukherjee S, et al. Causal factors for brain tumor and targeted strategies. In: Freund F, Langhoff S, editors. Universe of scales: from nanotechnology to cosmology: Symposium in Honor of Minoru M Freund. Springer Proceedings in Physics; Cham: Springer International Publishing; 2014. Vol. 150. p. 191–204.
   Google Scholar
• Yang T, Cui F-D, Choi M-K, et al. Enhanced solubility and stability of PEGylated liposomal paclitaxel: in vitro and in vivo evaluation. Int J Pharm. 2007;338:317–326.
   PubMed Web of Science ®Google Scholar
• Allen T, Hansen C. Pharmacokinetics of stealth versus conventional liposomes: effect of dose. Biochim Biophys Acta-Biomemb. 1991;1068:133–141.
   PubMed Web of Science ®Google Scholar
• Cattel L, Ceruti M, Dosio F. From conventional to stealth liposomes: a new frontier in cancer chemotherapy. Tumori. 2003;89:237–249.
   PubMed Web of Science ®Google Scholar
• Crosasso P, Ceruti M, Brusa P, et al. Preparation, characterization and properties of sterically stabilized paclitaxel-containing liposomes. J Control Release. 2000;63:19–30.
   PubMed Web of Science ®Google Scholar
• Yang T, Choi M-K, Cui F-D, et al. Preparation and evaluation of paclitaxel-loaded PEGylated immunoliposome. J Control Release. 2007;120:169–177.
   PubMed Web of Science ®Google Scholar
• Xu X, Khan MA, Burgess DJ. A quality by design (QbD) case study on liposomes containing hydrophilic API: I. Formulation, processing design and risk assessment. Int J Pharm. 2011;419:52–59.
   PubMed Web of Science ®Google Scholar
• Cortesi R. Preparation of liposomes by reverse-phase evaporation using alternative organic solvents. J Microencapsul. 1999;16:251–256.
   PubMed Web of Science ®Google Scholar
• Mozafari MR. Liposomes: an overview of manufacturing techniques. Cell Mol Biol Lett. 2005;10:711.
   PubMed Web of Science ®Google Scholar
• Vemuri S, Rhodes C. Preparation and characterization of liposomes as therapeutic delivery systems: a review. Pharm Acta Helv. 1995;70:95–111.
   PubMedGoogle Scholar
• Gandhi R, Khatri N, Baradia D, et al. Surface-modified Epirubicin-HCl liposomes and its in vitro assessment in breast cancer cell-line: MCF-7. Drug Deliv. 2016;23:1152–1162.
   PubMed Web of Science ®Google Scholar
• Juliano RL, Stamp D. The effect of particle size and charge on the clearance rates of liposomes and liposome encapsulated drugs. Biochem Biophys Res Commun. 1975;63:651–658.
   PubMed Web of Science ®Google Scholar
• Grabielle-Madelmont C, Lesieur S, Ollivon M. Characterization of loaded liposomes by size exclusion chromatography. J Biochem Biophys Methods. 2003;56:189–217.
   PubMedGoogle Scholar
• Panwar P, Pandey B, Lakhera P, et al. Preparation, characterization, and in vitro release study of albendazole-encapsulated nanosize liposomes. Int J Nanomed. 2010;5:8.
   Web of Science ®Google Scholar
• Gabizon A, Shmeeda H, Barenholz Y. Pharmacokinetics of pegylated liposomal Doxorubicin: review of animal and human studies. Clin Pharmacokinet. 2003;42:419–436.
   PubMed Web of Science ®Google Scholar
• Frokjaer S, Hjorth EL, Worts O. Stability testing of liposomes during storage. Liposome Technol. 1984;1:235–245.
   Google Scholar
• Guideline IHT. Stability testing of new drug substances and products. Q1A (R2), current step. 2003;4.
   Google Scholar
• Freitas C, Müller R. Correlation between long-term stability of solid lipid nanoparticles (SLN™) and crystallinity of the lipid phase. Eur J Pharm Biopharm. 1999;47:125–132.
   PubMed Web of Science ®Google Scholar
• Muthu MS, Feng S-S. Pharmaceutical stability aspects of nanomedicines. Nanomedicine (Lond). 2009;4:857–860.
   PubMed Web of Science ®Google Scholar
• Wicki A, Witzigmann D, Balasubramanian V, et al. Nanomedicine in cancer therapy: challenges, opportunities, and clinical applications. J Control Release. 2015;200:138–157.
   PubMed Web of Science ®Google Scholar
• Porfire A, Muntean DM, Rus L, et al. A quality by design approach for the development of lyophilized liposomes with simvastatin. Saudi Pharm J. 2017;25:981–992.
   PubMed Web of Science ®Google Scholar
• Tefas LR, Muntean D-M, Vlase L, et al. Quercetin-loaded liposomes: formulation optimization through a D-optimal experimental design. Farmacia. 2015;63:26–33.
   Web of Science ®Google Scholar
• Colletier J-P, Chaize B, Winterhalter M, et al. Protein encapsulation in liposomes: efficiency depends on interactions between protein and phospholipid bilayer. BMC Biotechnol. 2002;2:9.
   PubMedGoogle Scholar
• Jaafar-Maalej C, Diab R, Andrieu V, et al. Ethanol injection method for hydrophilic and lipophilic drug-loaded liposome preparation. J Liposome Res. 2010;20:228–243.
   PubMed Web of Science ®Google Scholar
• Kesisoglou F, Zhou SY, Niemiec S, et al. Liposomal formulations of inflammatory bowel disease drugs: local versus systemic drug delivery in a rat model. Pharm Res. 2005;22:1320–1330.
   PubMed Web of Science ®Google Scholar
• Zhou Q, Gallo JM. Differential effect of sunitinib on the distribution of temozolomide in an orthotopic glioma model. Neuro-oncology. 2009;11:301–310.
   PubMed Web of Science ®Google Scholar
• Nagayasu A, Uchiyama K, Kiwada H. The size of liposomes: a factor which affects their targeting efficiency to tumors and therapeutic activity of liposomal antitumor drugs. Adv Drug Deliv Rev. 1999;40:75–87.
   PubMed Web of Science ®Google Scholar
• Garg A, Bhalala K, Tomar DS. In-situ single pass intestinal permeability and pharmacokinetic study of developed Lumefantrine loaded solid lipid nanoparticles. Int J Pharm. 2017;516:120–130.
   PubMed Web of Science ®Google Scholar
• Khatri N, Baradia D, Vhora I, et al. Development and characterization of siRNA Lipoplexes: effect of different lipids, in vitro evaluation in cancerous cell lines and in vivo toxicity study. AAPS PharmSciTech. 2014;15:1630–1643.
   PubMed Web of Science ®Google Scholar
• Di Martino A, Kucharczyk P, Capakova Z, et al. Enhancement of temozolomide stability by loading in chitosan-carboxylated polylactide-based nanoparticles. J Nanopart Res. 2017;19:71.
   PubMed Web of Science ®Google Scholar
• Lanz‐Landázuri A, García‐Alvarez M, Portilla‐Arias J, et al. Poly (methyl malate) nanoparticles: formation, degradation, and encapsulation of anticancer drugs. Macromol Biosci. 2011;11:1370–1377.
   PubMed Web of Science ®Google Scholar
• Lee CY, Ooi IH. Preparation of temozolomide-loaded nanoparticles for glioblastoma multiforme targeting—ideal versus reality. Pharmaceuticals. 2016;9:54.
   Google Scholar
• Kaur IP, Bhandari R, Bhandari S, et al. Potential of solid lipid nanoparticles in brain targeting. J Control Release. 2008;127:97–109.
   PubMed Web of Science ®Google Scholar
• Jain SK, Jain RK, Chourasia MK, et al. Design and development of multivesicular liposomal depot delivery system for controlled systemic delivery of acyclovir sodium. AAPS PharmSciTech. 2005;6:E35–E41.
   PubMed Web of Science ®Google Scholar
• Shen Y, Ji Y, Xu S, et al. Multivesicular liposome formulations for the sustained delivery of ropivacaine hydrochloride: preparation, characterization, and pharmacokinetics. Drug Deliv. 2011;18:361–366.
   PubMed Web of Science ®Google Scholar
• Du Plessis J, Ramachandran C, Weiner N, et al. The influence of lipid composition and lamellarity of liposomes on the physical stability of liposomes upon storage. Int J Pharm. 1996;127:273–278.
   Web of Science ®Google Scholar
• He C, Hu Y, Yin L, et al. Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles. Biomaterials. 2010;31:3657–3666.
   PubMed Web of Science ®Google Scholar
• Carrion F, De La Maza A, Parra J. The influence of ionic strength and lipid bilayer charge on the stability of liposomes. J Colloid Interf Sci. 1994;164:78–87.
   Web of Science ®Google Scholar
• Puu G, Gustafson I. Planar lipid bilayers on solid supports from liposomes–factors of importance for kinetics and stability. Biochim Biophys Acta (BBA)-Biomembr. 1997;1327:149–161.
   PubMed Web of Science ®Google Scholar